Case Report: Response to Almonertinib in a Patient With Metastatic NSCLC Resistant to Osimertinib due to Acquired EGFR L718Q Mutation

• Gang Shen,
• Lei Shi,
• Xin Tian,
• Depei Huang,
• Hao Chen,
• Chan Gao,
• Xudong Shen,
• Hushan Zhang

Affiliations

Gang Shen

Department of Thoracic Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China

Lei Shi

Department of Thoracic Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China

Xin Tian

Department of Head and Neck Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China

Depei Huang

The Medical Department, 3D Medicines Inc., Shanghai, China

Hao Chen

The Bioinformatics Department, 3D Medicines Inc., Shanghai, China

Chan Gao

The Medical Department, 3D Medicines Inc., Shanghai, China

Xudong Shen

The Medical Department, 3D Medicines Inc., Shanghai, China

Hushan Zhang

The Medical Department, 3D Medicines Inc., Shanghai, China